1-4 of 4
Ruzanna Atoyan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers

Kaiming Sun, Ruzanna Atoyan, Mylissa A. Borek, Steven Dellarocca, Maria Elena S. Samson, Anna W. Ma, Guang-Xin Xu, Troy Patterson, David P. Tuck, Jaye L. Viner, Ali Fattaey, Jing Wang
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (2): 285–299.
https://doi.org/10.1158/1535-7163.MCT-16-0390
Published: 02 February 2017
View article titled, Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers
Open the PDF for Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers in another window
Includes: Supplementary data
Journal Articles

Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion

Jing Wang, Natalie W. Pursell, Maria Elena S. Samson, Ruzanna Atoyan, Anna W. Ma, Abdelkader Selmi, Wanlu Xu, Xiong Cai, Maurizio Voi, Pierre Savagner, Cheng-Jung Lai
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2013) 12 (6): 925–936.
https://doi.org/10.1158/1535-7163.MCT-12-1045
Published: 09 June 2013
View article titled, Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion
Open the PDF for Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion in another window
Includes: Supplementary data
Journal Articles

Abstract C70: Antitumor activity of CUDC-907, a single small molecule inhibitor that targets both PI3K and HDAC, in hematologic cancer models.

Rudi Bao, Dagong Wang, Hui Qu, Jing Wang, Ruzanna Atoyan, Guang-Xin Xu, Ling Yin, Brian Zifcak, Mylissa Borek, Maria Samson, Anna Ma, Steven DellaRocca, Hai-Xiao Zhai, Cheng-Jung Lai, Carmen Pepicelli, Xiong Cai, Changgeng Qian
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): C70.
https://doi.org/10.1158/1535-7163.TARG-11-C70
Published: 12 November 2011
View article titled, Abstract C70: Antitumor activity of CUDC-907, a single small molecule inhibitor that targets both PI3K and HDAC, in hematologic cancer models.
Journal Articles

Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer

Rudi Bao, Cheng-Jung Lai, Da-Gong Wang, Hui Qu, Ling Yin, Brian Zifcak, Xu Tao, Jing Wang, Ruzanna Atoyan, Maria Samson, Jeffrey Forrester, Guang-Xin Xu, Steven DellaRocca, Mylissa Borek, Hai-Xiao Zhai, Xiong Cai, Changgeng Qian
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12): 3296–3306.
https://doi.org/10.1158/1535-7163.MCT-09-0538
Published: 09 December 2009
View article titled, Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer
Open the PDF for Targeting heat shock protein 90 with CUDC-305 overcomes erlotinib resistance in non–small cell lung cancer in another window